SPECT & PET Radiopharmaceuticals Market - Global Forecast 2026-2032

The SPECT & PET Radiopharmaceuticals Market is experiencing dynamic transformation as advanced molecular imaging becomes integral to precision diagnostics and optimized patient pathways. Senior decision-makers in healthcare, life sciences, and diagnostics are increasingly focused on operational resilience, clinical integration, and aligning supply with evolving regulatory expectations across global networks.

Market Snapshot: Growth Trajectory of the SPECT & PET Radiopharmaceuticals Market

The SPECT & PET Radiopharmaceuticals Market expanded from USD 7.48 billion in 2025 to USD 8.18 billion in 2026. It is projected to continue its upward path at a CAGR of 10.28%, reaching USD 14.85 billion by 2032. This robust growth is a direct result of healthcare systems prioritizing nuclear medicine solutions for complex diagnostic and therapeutic needs, particularly in markets where clinical evidence and payor requirements are rapidly evolving. Vendors, suppliers, and hospital networks are adjusting strategies around these trends to capitalize on emerging consensus and maximize technology ROI.

Scope & Segmentation

This report provides actionable intelligence for leaders navigating the nuclear medicine and diagnostics landscape, addressing critical decision points across modalities, supply chain, and clinical implementation:

Modality: Analysis distinguishes between SPECT and PET, clarifying roles in diagnostic workflows, implications for scalability, and capital equipment decisions.
Isotope Families: Evaluates operational impacts of short-lived PET isotopes, which necessitate proximity and sophisticated logistics, compared with widely distributed SPECT isotopes that streamline access and distribution planning.
Clinical Applications: Assesses how innovation and new imaging protocols are advancing use in oncology, cardiology, and neurology, charting technology uptake and downstream impact on therapy choices.
End Users: Examines purchasing behaviors of hospital networks, imaging centers, and academic institutions, noting varied needs around standardization, workforce management, and preferred distribution models.
Workflow Models: Identifies market shifts driven by adoption of ready-to-use versus on-site prepared doses, and evaluates centralized production versus local compounding from operational and economic perspectives.
Geographic Regions: Coverage includes the Americas, Europe, Middle East & Africa, and Asia-Pacific, highlighting differences in infrastructure maturity, reimbursement policy, and supply chain resilience shaping regional market dynamics.

Key Takeaways for Senior Decision-Makers

Radiopharmaceuticals are increasingly recognized as pivotal assets in diagnostic and therapeutic strategies for oncology, cardiology, and neurology, elevating their role in care management.
End-to-end supply assurance is now paramount, with integrated reliability surpassing traditional product-focused differentiation to ensure regulatory compliance and trust across distributed networks.
Theranostics is forging new clinical pathways by linking imaging agents directly with targeted therapies, informing both product choice and procedural adoption throughout care delivery.
Industrialization and automation are streamlining radiopharmacy operations, as standardized protocols and ready-to-use formulations address operational bottlenecks and support workforce continuity.
Divergent regional regulatory frameworks, isotopic supply constraints, and varying access to clinical infrastructure set the pace and pattern for adoption across key markets.
Enhanced evidence standards are shaping market entry and growth, as payers and providers require alignment with real-world protocols and outcomes across expanding provider networks.

Impact of US Tariffs on Radiopharmaceutical Supply Chains

Recent US tariffs in 2025 have complicated sourcing and cost management for radiopharmaceutical suppliers. Cross-border components including synthesis modules, shielding materials, and quality control systems now face higher costs and potential delays. PET centers operating on tight production schedules are particularly exposed to disruptions in critical inputs. In response, organizations are adopting dual sourcing strategies, building up safety stocks, and diversifying supplier bases through nearshoring. These measures must meet rigorous compliance requirements and proactively minimize operational risk, underscoring the necessity for robust supply assurance planning. Shifts in tariff conditions are also reshaping investment calculations and elevating operational continuity in vendor selection.

Methodology & Data Sources

This report is based on structured primary interviews with stakeholders along the radiopharmaceutical supply chain, including manufacturers, radiopharmacy operators, imaging providers, and clinical specialists. Coverage is supplemented by rigorous analysis of regulatory filings, scientific publications, and up-to-date company disclosures. Triangulation and cross-validation processes validate reliability from isotope production through to clinical use.

Why This Report Matters

Supports informed, data-driven decisions on investments, network planning, and portfolio management in a rapidly regulated sector.
Enables more effective technology adoption and risk mitigation through clear segmentation by workflow, modality, and region.
Delivers practical intelligence for navigating supply chain volatility and regulatory change, providing a sustainable growth framework for executive leadership.

Conclusion

As market requirements shift, operational reliability and clinical impact are the key levers for sustained growth in the SPECT & PET Radiopharmaceuticals Market. Leaders will distinguish themselves by seamlessly scaling solutions and supporting evidence-driven adoption strategies across dynamic care environments.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. SPECT & PET Radiopharmaceuticals Market, by Modality

8.1. PET
8.2. SPECT

9. SPECT & PET Radiopharmaceuticals Market, by Radiopharmaceutical Type

9.1. Fluorine 18
9.1.1. FDG
9.1.2. Non FDG
9.2. Gallium 68
9.3. Indium 111
9.4. Iodine 123
9.5. Technetium 99M
9.5.1. Cold Kits
9.5.2. Ready To Use

10. SPECT & PET Radiopharmaceuticals Market, by Indication

10.1. Cardiology
10.2. Neurology
10.3. Oncology

11. SPECT & PET Radiopharmaceuticals Market, by End User

11.1. Academic And Research Institutes
11.2. Diagnostic Centers
11.3. Hospitals

12. SPECT & PET Radiopharmaceuticals Market, by Distribution Channel

12.1. Offline
12.2. Online

13. SPECT & PET Radiopharmaceuticals Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. SPECT & PET Radiopharmaceuticals Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. SPECT & PET Radiopharmaceuticals Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States SPECT & PET Radiopharmaceuticals Market
17. China SPECT & PET Radiopharmaceuticals Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Advanced Accelerator Applications
18.6. Bayer AG
18.7. Bracco Imaging S.p.A.
18.8. Cardinal Health, Inc.
18.9. Curium Pharma
18.10. Eckert & Ziegler
18.11. GE Healthcare
18.12. IBA Molecular
18.13. Isotopia Molecular Imaging Ltd.
18.14. Jubilant Pharma Limited
18.15. Lantheus Holdings, Inc.
18.16. Life Molecular Imaging GmbH
18.17. Mallinckrodt plc
18.18. Nihon Medi-Physics Co., Ltd.
18.19. NorthStar Medical Radioisotopes, LLC
18.20. Novartis AG
18.21. Positron Corporation
18.22. Spectrum Pharmaceuticals, Inc.
18.23. Telix Pharmaceuticals Limited

List of Figures

FIGURE 1. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FDG, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FDG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FDG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NON FDG, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NON FDG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NON FDG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM 68, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM 68, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM 68, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDIUM 111, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDIUM 111, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDIUM 111, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE 123, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE 123, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE 123, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COLD KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COLD KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COLD KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY READY TO USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY READY TO USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY READY TO USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. EUROPE SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. EUROPE SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 101. EUROPE SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 103. EUROPE SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 104. EUROPE SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 105. EUROPE SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. EUROPE SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 117. AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 118. AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 119. AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 120. AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 121. AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. ASEAN SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASEAN SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 134. ASEAN SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 135. ASEAN SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 136. ASEAN SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 137. ASEAN SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 138. ASEAN SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. ASEAN SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. GCC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GCC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 142. GCC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 143. GCC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 144. GCC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 145. GCC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 146. GCC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. GCC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 156. BRICS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. BRICS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 158. BRICS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 159. BRICS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 160. BRICS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 161. BRICS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 162. BRICS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. BRICS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. G7 SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. G7 SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 166. G7 SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 167. G7 SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 168. G7 SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 169. G7 SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 170. G7 SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. G7 SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. NATO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. NATO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 174. NATO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 175. NATO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 176. NATO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 177. NATO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 178. NATO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. NATO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. CHINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 190. CHINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 191. CHINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2032 (USD MILLION)
TABLE 192. CHINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE 18, 2018-2032 (USD MILLION)
TABLE 193. CHINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM 99M, 2018-2032 (USD MILLION)
TABLE 194. CHINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 195. CHINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. CHINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this SPECT & PET Radiopharmaceuticals market report include:

Advanced Accelerator Applications
Bayer AG
Bracco Imaging S.p.A.
Cardinal Health, Inc.
Curium Pharma
Eckert & Ziegler
GE Healthcare
IBA Molecular
Isotopia Molecular Imaging Ltd.
Jubilant Pharma Limited
Lantheus Holdings, Inc.
Life Molecular Imaging GmbH
Mallinckrodt plc
Nihon Medi-Physics Co., Ltd.
NorthStar Medical Radioisotopes, LLC
Novartis AG
Positron Corporation
Spectrum Pharmaceuticals, Inc.
Telix Pharmaceuticals Limited

Table Information

Report Attribute	Details
No. of Pages	189
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 8.18 Billion
Forecasted Market Value ( USD ) by 2032	$ 14.85 Billion
Compound Annual Growth Rate	10.2%
Regions Covered	Global
No. of Companies Mentioned	20

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3513EUR$3,939USD£3,047GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3789EUR$4,249USD£3,286GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5136EUR$5,759USD£4,454GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6215EUR$6,969USD£5,390GBP

Market Snapshot: Growth Trajectory of the SPECT & PET Radiopharmaceuticals Market

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Impact of US Tariffs on Radiopharmaceutical Supply Chains

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2026-2032

Diagnostic Radiopharmaceuticals Market - Global Forecast 2026-2032

Radiopharmaceuticals Market - Products and Applications

Radiopharmaceutical Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

Radiopharmaceuticals Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034)